Entero Healthcare Solutions Limited has announced the incorporation of its new step-down subsidiary, Qurovia Lifesciences Private Limited. The subsidiary, with an authorized share capital of ₹1.5 crore, was incorporated on July 25, 2026. Qurovia Lifesciences will focus on the marketing, distribution, import, and export of pharmaceuticals and healthcare products, aiming to expand Entero’s market reach and service offerings.
Entero Healthcare Establishes New Subsidiary
Entero Healthcare Solutions Limited has officially announced the incorporation of its step-down subsidiary, named Qurovia Lifesciences Private Limited. The incorporation date for the new entity is recorded as July 25, 2026, with its registered office located in Bangalore, Karnataka, India. This development signifies a strategic move by Entero Healthcare to broaden its operational scope and market presence within the pharmaceutical and healthcare sector.
Subsidiary Details and Business Focus
Qurovia Lifesciences Private Limited has been established as a wholly owned subsidiary of R S M Pharma Private Limited, which is itself a wholly owned subsidiary of Entero Healthcare Solutions Limited. The subsidiary has an authorized share capital of ₹1,50,00,000 (Rupees One Crore Fifty Lakh), divided into 15,00,000 equity shares of ₹10 each. The initial subscription of 10,000 equity shares by R S M Pharma Private Limited, aggregating to ₹1,00,000, has been completed. The primary business objective of Qurovia Lifesciences will encompass the marketing, distribution, import, and export of pharmaceuticals, healthcare products and services, medical devices, diagnostics, healthcare technologies, and related allied healthcare activities.
Regulatory Compliance and Future Outlook
The incorporation aligns with Entero Healthcare’s ongoing strategy to strengthen its position in the market through targeted expansion and diversification. The company has confirmed that all necessary disclosures as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, have been made. The information regarding this incorporation will also be made available on Entero Healthcare’s official website.
Source: BSE
